Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2019 07:00 ET | Source: Bioxytran Inc.

Latest Nobel Prize Validates Bioxytran at the Forefront of Scientific Discovery

Platform technology destined to measure and treat hypoxia BOSTON, MASSACHUSETTS, Oct. 16, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), is a developmental stage biotechnology...
September 13, 2019 14:39 ET | Source: Bioxytran Inc.

Bioxytran Inc. Appoints Two Investment Bankers from Westbury Group to Its Advisory Board

BOSTON, MASSACHUSETTS, Sept. 13, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company, focused on delivering a small molecule carrying oxygen to the...
August 30, 2019 14:31 ET | Source: Bioxytran Inc.

Bioxytran Inc. to Attend Multiple Investor Conferences in September

BOSTON, MASSACHUSETTS, Aug. 30, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to treat...
August 08, 2019 07:00 ET | Source: Bioxytran Inc.

Bioxytran Inc. Announces Appointment of Dr. Hana Chen-Walden to Scientific Advisory Board

BOSTON, MASSACHUSETTS, Aug. 08, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
August 01, 2019 07:00 ET | Source: Bioxytran Inc.

Bioxytran Inc. Appoints Cynthia Ekberg Tsai to Company Advisory Board

BOSTON, MASSACHUSETTS, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...
July 26, 2019 15:52 ET | Source: Bioxytran Inc.

Bioxytran Inc. Bolsters Advisory Board with Addition of Veteran Financial Advisor Jonathan Barkman

BOSTON, July 26, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat hypoxia by...
July 23, 2019 07:00 ET | Source: Bioxytran Inc.

Avise Analytics Initiates Coverage on Bioxytran Inc.

BOSTON, MASSACHUSETTS, July 23, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
July 09, 2019 13:54 ET | Source: Bioxytran Inc.

Bioxytran Inc. Invited to New York Venture Summit

BOSTON, MASSACHUSETTS, July 09, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
June 12, 2019 07:00 ET | Source: Bioxytran Inc.

Bioxytran, Inc. Announces Public Company Executive Steve Aust to Join Advisory Board

BOSTON, MASSACHUSETTS, June 12, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of novel anti-necrosis drugs designed to...
June 06, 2019 07:00 ET | Source: Bioxytran Inc.

BIOXYTRAN’S MDX VIEWER DEMONSTRATES EARLY WARNING SIGNS OF BRAIN HEALTH DURING CARDIOVASCULAR SURGERIES

MDX Viewer use during open heart surgery is an essential vital sign that could mitigate the risk of brain damage caused by prolonged oxygen deprivation during perioperative cardiovascular procedures...